Tecovirimat (TPOXX)

People with monkeypox must not be left to suffer in pain while an approved drug sits on the shelf unused - Jay K. Varma & Joseph Osmundson

Tecovirimat (TPOXX)

image by: Kapisanang Agham ng San Beda
     

HWN Recommends

Monkeypox patients should not be left to suffer when an FDA-approved drug could help

We believe there is an urgent need for the federal government to simultaneously align two public health objectives: make it easier for people with monkeypox to get tecovirimat and collect high-quality data on its effectiveness.

It is important to understand the history of tecovirimat, because it represents the impressive success of U.S. government pandemic preparedness and its simultaneous failure at pandemic response.

read full article

Resources

Related Articles

Stay Connected

©2022 | HealthWorldNet, Inc. | 117583

Last Updated : Saturday, September 10, 2022